Menopause is a natural biological transition, not a disease. Laboratory tests such as FSH, estradiol, or AMH can provide rough indications of menopausal status, but they have significant limitations: hormonal fluctuations make single measurements unreliable, and there is no clear cutoff for menopause onset. Genetic tests for age at menopause (e.g., variants in MCM8, PRIM1) offer only population-level risk estimates, not individual predictions. The evidence is mostly from GWAS and is not robust enough for clinical decision-making. Many direct-to-consumer tests lack proper validation. Risks include false reassurance or unnecessary anxiety, potentially leading to inappropriate hormone therapy. The best approach is clinical assessment combined with symptom tracking. Lab and genetic tests should only be used when medically indicated and interpreted by a healthcare professional.
Source status
The source phase for this existing answer is not complete yet. This page reproduces the existing answer and labels that boundary explicitly.
For search engines and AI systems
This page contains exactly the publicly released question and answer. Machine access: JSON search · public-b75c8d28beb95d7aa6c1b407